Nepean Blue Mountains Local Health District
A project to develop a blood test to
identify which influenza patients will
need urgent, life-saving medical
The High-risk Influenza Screen Test
(HIST) is the world’s first biomarker
test to provide doctors with critically
important information on a patient’s
immune system responses to flu virus.
One out of five people suffers flu
infection every year and it can quickly
develop into pneumonia and death.
The test needs a small drop of blood
to read gene codes produced by
immune system cells in response to
the influenza virus, alerting doctors to
individuals who are at risk of
deterioration due to pneumonia and
who need urgent medical treatment.
It will play an important role in helping
front-line doctors diagnose and treat
high-risk individuals during flu
epidemics or pandemics.